• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用精神活性物质及针对焦虑和抑郁障碍的医疗保健措施。

Use of psychoactive substances and health care in response to anxiety and depressive disorders.

作者信息

Encrenaz Gaëlle, Kovess-Masféty Viviane, Jutand Marthe-Aline, Carmona Elodie, Sapinho David, Messiah Antoine

机构信息

Institut National de la Santé et de la Recherche Médicale, Bordeaux, France.

出版信息

Psychiatr Serv. 2009 Mar;60(3):351-7. doi: 10.1176/ps.2009.60.3.351.

DOI:10.1176/ps.2009.60.3.351
PMID:19252048
Abstract

OBJECTIVES

The use of psychoactive substances in response to psychological distress is not well documented in the general population and has never been studied in combination with health care use. This study estimated the frequency of health care and substance use in response to anxiety or depressive disorders and determined factors associated with these behaviors.

METHODS

From a large survey of adults from four French regions, the authors selected those with a 12-month probable anxiety or depressive disorder without a substance use disorder (N=4,071). These disorders were determined with the Composite International Diagnostic Interview Short Form, and participants were asked whether they used substances or health care in response to each disorder.

RESULTS

The use of substances in response to anxiety or depressive disorders was 12.9% among men and 5.2% among women. Compared with those who used health care only, those who used substances (with or without health care) were more likely to be men, single, and young. Those who used both substances and health care were also less likely to have a depressive disorder.

CONCLUSIONS

This study shows that a sizeable portion of the general population uses substances in response to anxiety or depressive disorders. It also shows that these substance users have distinctive sociodemographic characteristics and can thus be targeted by prevention programs. Strategies to reach substance users with depressive or anxiety disorders who do not use health care remain to be elaborated.

摘要

目的

在普通人群中,使用精神活性物质来应对心理困扰的情况尚无充分记录,且从未与医疗保健使用情况结合起来进行研究。本研究估计了因焦虑或抑郁障碍而使用医疗保健和物质的频率,并确定了与这些行为相关的因素。

方法

作者从对法国四个地区成年人的一项大型调查中,选取了那些患有12个月可能的焦虑或抑郁障碍但无物质使用障碍的人(N = 4071)。这些障碍通过综合国际诊断访谈简表确定,并询问参与者是否针对每种障碍使用过物质或医疗保健。

结果

因焦虑或抑郁障碍而使用物质的情况在男性中为12.9%,在女性中为5.2%。与仅使用医疗保健的人相比,使用物质(无论是否使用医疗保健)的人更可能是男性、单身且年轻。同时使用物质和医疗保健的人患抑郁症的可能性也较小。

结论

本研究表明,相当一部分普通人群使用物质来应对焦虑或抑郁障碍。研究还表明,这些物质使用者具有独特的社会人口学特征,因此预防项目可以针对他们。针对不使用医疗保健的抑郁或焦虑障碍物质使用者的干预策略仍有待制定。

相似文献

1
Use of psychoactive substances and health care in response to anxiety and depressive disorders.使用精神活性物质及针对焦虑和抑郁障碍的医疗保健措施。
Psychiatr Serv. 2009 Mar;60(3):351-7. doi: 10.1176/ps.2009.60.3.351.
2
[Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].[使用患者健康问卷评估法国全科医疗中精神障碍的患病率:与全科医生病例识别及精神药物处方的比较]
Encephale. 2009 Dec;35(6):560-9. doi: 10.1016/j.encep.2008.06.018.
3
The quality of care for depressive and anxiety disorders in the United States.美国抑郁和焦虑症的护理质量。
Arch Gen Psychiatry. 2001 Jan;58(1):55-61. doi: 10.1001/archpsyc.58.1.55.
4
Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care.抑郁症合并焦虑症:世界卫生组织初级卫生保健中心理障碍研究的结果
Br J Psychiatry Suppl. 1996 Jun(30):38-43.
5
Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders.患有焦虑症的初级保健患者对精神药物和心理治疗的看法。
Depress Anxiety. 2005;21(3):99-105. doi: 10.1002/da.20067.
6
Health care costs associated with depressive and anxiety disorders in primary care.初级保健中与抑郁和焦虑症相关的医疗保健费用。
Am J Psychiatry. 1995 Mar;152(3):352-7. doi: 10.1176/ajp.152.3.352.
7
[Cross-sectional study of the prevalence of adjustment disorder with anxiety in general practice].[全科医疗中焦虑性适应障碍患病率的横断面研究]
Encephale. 2001 May-Jun;27(3):238-44.
8
Efficacy of a cognitive and behavioural psychotherapy applied by primary care psychologists in patients with mixed anxiety-depressive disorder: a research protocol.初级保健心理学家应用的认知与行为心理疗法对混合性焦虑抑郁障碍患者的疗效:一项研究方案
BMC Fam Pract. 2015 Mar 20;16:39. doi: 10.1186/s12875-015-0248-3.
9
[Comorbidity in 207 cannabis users in a specific outpatient setting].[特定门诊环境中207名大麻使用者的合并症]
Encephale. 2015 Jun;41 Suppl 1:S7-12. doi: 10.1016/j.encep.2014.06.004. Epub 2014 Aug 12.
10
[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].[门诊特定环境下大麻使用者的社会人口学特征、成瘾及精神共病情况]
Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19.

引用本文的文献

1
Assessment of the Relationship of Depression With Tobacco and Caffeine Use Among University Students: A Cross-Sectional Study.大学生中抑郁症与烟草和咖啡因使用关系的评估:一项横断面研究。
Cureus. 2021 Oct 28;13(10):e19098. doi: 10.7759/cureus.19098. eCollection 2021 Oct.
2
Posttraumatic Stress Disorder and Adjustment Disorder in Lithuanian Healthcare in 2018-2020: A Nation-Wide Cohort Study of the Effects of COVID-19 Pandemic.2018 - 2020年立陶宛医疗保健领域的创伤后应激障碍和适应障碍:一项关于新冠疫情影响的全国队列研究
Healthcare (Basel). 2021 Oct 22;9(11):1422. doi: 10.3390/healthcare9111422.
3
Psychoactive substance abuse and dependence and its association with anxiety disorders: a population-based study of young adults in Brazil.
精神活性物质滥用和依赖及其与焦虑障碍的关系:巴西青年的一项基于人群的研究。
Braz J Psychiatry. 2018 Oct-Dec;40(4):349-353. doi: 10.1590/1516-4446-2017-2258. Epub 2018 Feb 15.
4
Risk compensation: a male phenomenon? Results from a controlled intervention trial promoting helmet use among cyclists.风险补偿:男性现象?一项促进自行车骑手戴头盔的对照干预试验结果。
Am J Public Health. 2012 May;102 Suppl 2(Suppl 2):S204-6. doi: 10.2105/AJPH.2012.300711.